Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001544227-16-000013
Filing Date
2016-08-04
Accepted
2016-08-04 16:10:01
Documents
45
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovas-20160630x10q.htm 10-Q 646768
2 EXHIBIT 31.1 ovas-20160630xex311.htm EX-31.1 13114
3 EXHIBIT 31.2 ovas-20160630xex312.htm EX-31.2 12395
4 EXHIBIT 32.1 ovas-20160630xex321.htm EX-32.1 8221
5 EXHIBIT 32.2 ovas-20160630xex322.htm EX-32.2 7475
  Complete submission text file 0001544227-16-000013.txt   3160149

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovas-20160630.xml EX-101.INS 605467
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20160630.xsd EX-101.SCH 22147
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20160630_cal.xml EX-101.CAL 43441
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20160630_def.xml EX-101.DEF 102560
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovas-20160630_lab.xml EX-101.LAB 348832
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20160630_pre.xml EX-101.PRE 187184
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 161807490
SIC: 2834 Pharmaceutical Preparations